Current evidence on abuse and misuse of gabapentinoids

S Hägg, AK Jönsson, J Ahlner - Drug safety, 2020 - Springer
This review summarizes current evidence on the abuse and misuse of the gabapentinoids
pregabalin and gabapentin. Pharmacovigilance studies, register-based studies, surveys …

The gabapentinoid drugs and their abuse potential

A Goins, K Patel, SRA Alles - Pharmacology & Therapeutics, 2021 - Elsevier
The gabapentinoid drugs, gabapentin and pregabalin, are first-line treatments for
neuropathic pain. The epidemics of chronic pain and opioid misuse have given rise to the …

Post-marketing safety concerns with esketamine: a disproportionality analysis of spontaneous reports submitted to the FDA adverse event reporting system

C Gastaldon, E Raschi, JM Kane, C Barbui… - Psychotherapy and …, 2020 - karger.com
Introduction: Esketamine nasal spray received approval for treatment-resistant depression in
March 2019. Objective: Using the FDA Adverse Event Reporting System (FAERS) database …

Gabapentinoid abuse in France: evidence on health consequences and new points of vigilance

M Tambon, C Ponté, E Jouanjus, N Fouilhé… - Frontiers in …, 2021 - frontiersin.org
Introduction: Gabapentinoid drugs (gabapentin and pregabalin) are widely used worldwide
for epileptic and pain disorders. First signals of gabapentinoid abuse occurred in the last …

[HTML][HTML] Pharmacovigilance signals of the opioid epidemic over 10 years: Data mining methods in the analysis of pharmacovigilance datasets collecting adverse drug …

S Chiappini, R Vickers-Smith, A Guirguis, JM Corkery… - Pharmaceuticals, 2022 - mdpi.com
In the past twenty years, the consumption of opioid medications has reached significant
proportions, leading to a rise in drug misuse and abuse and increased opioid dependence …

[HTML][HTML] Gabapentin

R Yasaei, S Katta, P Patel, A Saadabadi - StatPearls [Internet], 2024 - ncbi.nlm.nih.gov
Gabapentin - StatPearls - NCBI Bookshelf US flag An official website of the United States
government Here's how you know NIH NLM Logo Access keys NCBI Homepage MyNCBI …

Neonatal withdrawal syndrome following in utero exposure to antidepressants: a disproportionality analysis of VigiBase, the WHO spontaneous reporting database

C Gastaldon, E Arzenton, E Raschi, O Spigset… - Psychological …, 2023 - cambridge.org
BackgroundEvidence on neonatal withdrawal syndrome following antidepressant
intrauterine exposure is limited, particularly for antidepressants other than selective …

[HTML][HTML] An enhanced recovery after surgery protocol for facial feminization surgery reduces perioperative opioid usage, pain, and hospital stay

M Bedar, D Dejam, RM Caprini, KX Huang… - Journal of Plastic …, 2023 - Elsevier
Background Prescription drug misuse in transgender individuals is estimated to be three
times higher than that of the general population in the United States, suggesting that opioid …

State-level response to gabapentin misuse in the United States: implications and future direction

ZA Karavolis, AB Su, AM Peckham - American Journal of Health …, 2022 - academic.oup.com
Purpose Gabapentin misuse is on the rise and has forced many US states to mobilize
policies to address this public health concern. The purpose of this manuscript is to update …

N-palmitoylethanolamide synergizes the antinociception of morphine and gabapentin in the formalin test in mice

M Déciga-Campos… - Journal of Pharmacy …, 2023 - academic.oup.com
Objective The antinociceptive pharmacological interaction between N-
palmitoylethanolamide (PEA) and morphine (MOR), as well as gabapentin (GBP), was …